Timothy Mansouri
Pain Management · Folsom, CANPI 1770970899
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 32.4% of the total. Among pain management clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$890
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$500
- Forte Bio-pharma LLC$287
- Ardelyx, Inc.$286
- Pfizer$188
- Collegium Pharmaceutical, Inc.$167
- plus $429 from 7 others
What the payments were for
- Food & beverage$2,748100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $890 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $500 |
| Forte Bio-pharma LLC | 21 | $287 |
| Ardelyx, Inc. | 14 | $286 |
| Pfizer | 11 | $188 |
| Collegium Pharmaceutical, Inc. | 12 | $167 |
| Scilex Pharmaceuticals Inc. | 8 | $143 |
| Vertex | 4 | $102 |
| Merz Pharmaceuticals, LLC | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Bioventus LLC | 1 | $34 |
| Vertos Medical, Inc. | 1 | $26 |
| Electronic Waveform Lab, Inc. | 1 | $25 |
How this compares
$2,748 in reported general payments places this provider in the 95th percentile of 26 pain management providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZtlidoLidocaine | 142 | $88,497 |
| BelbucaBuprenorphine Hcl | 120 | $81,186 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,108 | $66,458 |
| RelistorMethylnaltrexone Bromide | 30 | $59,488 |
| OxycontinOxycodone Hcl | 108 | $48,090 |
| Buprenorphine | 142 | $32,948 |
| MovantikNaloxegol Oxalate | 70 | $28,110 |
| Xtampza ErOxycodone Myristate | 50 | $26,489 |
| Lidocaine | 200 | $20,027 |
| Diclofenac Sodium | 198 | $19,558 |
| Hysingla ErHydrocodone Bitartrate | 29 | $19,073 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 456 | $15,697 |
| Nucynta ErTapentadol Hcl | 16 | $14,921 |
| ZavzpretZavegepant Hcl | 11 | $11,544 |
| LyricaPregabalin | 11 | $10,672 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er | $167 | $122,596186 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $143 | $88,497142 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $500 | $59,48830 claims |
| PfizerZavzpret, Lyrica | $188 | $22,21622 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 26 pain management providers in California.
Other pain management in Folsom
- George PerdikisRidgecrest$3K
- Doanh NguyenWestminster$2K
- Alexander Krakovskyla Jolla$935
- Anthony TranLos Angeles$454
- Kellie BinderOrange$315
- Nimish ShahHawaiian Gardens$292
- Jennifer ZubickPalmdale$291
- Carolyn HiranoLos Gatos$121
- Peter SchmidtStanford$0
- Sean MackeyStanford$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.